Initial Treatment for Pediatric Hypertriglyceridemia

Assessment and Classification

The American Heart Association recommends evaluating pediatric patients with hypertriglyceridemia for potential secondary causes, including diabetes, thyroid disease, renal disease, and alcohol use, to determine the underlying cause of the condition 1
The target goal for fasting triglycerides in pediatric patients is <150 mg/dL, according to the American Diabetes Association 1, 3

The American Academy of Pediatrics recommends implementing medical nutrition therapy with a trained dietitian to help pediatric patients with hypertriglyceridemia make dietary changes, including limiting total calories from fat to 25-30% and saturated fat to <7% of total calories 1, 2, 4
The American Heart Association suggests limiting dietary cholesterol to <200 mg/day and avoiding trans fats completely to help reduce triglyceride levels 4
Increasing dietary n-3 fatty acids (fish oils) and replacing simple carbohydrates with complex carbohydrates may also help reduce triglyceride levels, according to the American Academy of Pediatrics 4, 5
Eliminating sugar-sweetened beverages and decreasing simple sugar intake can also help reduce triglyceride levels, as recommended by the American Academy of Pediatrics 5
Achieving and maintaining a BMI <95th percentile for age and sex through a family-centered behavioral management approach for weight control is recommended by the American Heart Association 1, 6
Encouraging at least 1 hour per day of moderate-to-vigorous physical activity and limiting sedentary screen time to no more than 2 hours per day can also help reduce triglyceride levels, according to the American Academy of Pediatrics 5

The American Heart Association recommends considering pharmacological interventions for pediatric patients with hypertriglyceridemia when triglycerides ≥400 mg/dL fasting or ≥1,000 mg/dL non-fasting, or when lifestyle modifications have failed after 6 months of consistent effort 1, 4
Fibrates may be considered as first-line pharmacological therapy to reduce the risk of pancreatitis in pediatric patients with triglycerides >400 mg/dL fasting or >1,000 mg/dL non-fasting, according to the American Diabetes Association 4
Consultation with a physician experienced in pediatric lipid disorders is recommended before starting medication, as suggested by the American Heart Association 1
For combined dyslipidemia with elevated LDL and triglycerides, statins may be considered if LDL remains >130 mg/dL after 6 months of dietary intervention, according to the American Diabetes Association 4

The American Heart Association notes that hypertriglyceridemia is often seen in the context of overweight with insulin resistance, and addressing weight management is crucial 1
For children with very severe hypertriglyceridemia (>1,000 mg/dL), consultation with a lipid specialist is strongly recommended by the American Academy of Pediatrics 2, 5
Female adolescents of childbearing age should receive reproductive counseling if medications are being considered, as some lipid-lowering medications have teratogenic effects, according to the American Diabetes Association 4
Monitoring liver function tests, creatine kinase, and symptoms of muscle toxicity is recommended for children taking lipid-lowering medications, as suggested by the American Academy of Pediatrics 5

The American Diabetes Association recommends checking lipid profiles annually once stabilized, to monitor the effectiveness of treatment and adjust as needed 4